ACMG sets new lifelong guidelines for managing phenylalanine hydroxylase deficiency Post author: Post published:December 4, 2024 Post category:uncategorized Updated evidence-based clinical guidelines for phenylalanine hydroxylase deficiency diagnosis and management. You Might Also Like A new framework for assessing the impact of chemicals on child health January 9, 2025 Gaza’s life expectancy halved amid ongoing conflict January 25, 2025 New insights into PTSD’s genetic architecture unveiled by Dr. Kerry Ressler February 4, 2025